Nanjing Julong Science & TechnologyLTD Balance Sheet Health
Financial Health criteria checks 5/6
Nanjing Julong Science & TechnologyLTD has a total shareholder equity of CN¥921.5M and total debt of CN¥498.6M, which brings its debt-to-equity ratio to 54.1%. Its total assets and total liabilities are CN¥2.2B and CN¥1.3B respectively. Nanjing Julong Science & TechnologyLTD's EBIT is CN¥110.6M making its interest coverage ratio 4.1. It has cash and short-term investments of CN¥211.5M.
Key information
54.1%
Debt to equity ratio
CN¥498.62m
Debt
| Interest coverage ratio | 4.1x |
| Cash | CN¥211.45m |
| Equity | CN¥921.53m |
| Total liabilities | CN¥1.32b |
| Total assets | CN¥2.24b |
Recent financial health updates
No updates
Recent updates
Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) 39% Share Price Surge Not Quite Adding Up
Oct 08
Nanjing Julong Science & TechnologyLTD (SZSE:300644) Is Looking To Continue Growing Its Returns On Capital
Sep 30Little Excitement Around Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) Earnings As Shares Take 26% Pounding
Jul 19Nanjing Julong Science & TechnologyLTD (SZSE:300644) Is Paying Out A Larger Dividend Than Last Year
Jul 05There's Reason For Concern Over Nanjing Julong Science & Technology Co.,LTD's (SZSE:300644) Massive 35% Price Jump
Apr 25There's Been No Shortage Of Growth Recently For Nanjing Julong Science & TechnologyLTD's (SZSE:300644) Returns On Capital
Apr 02Nanjing Julong Science & Technology Co.,LTD (SZSE:300644) Held Back By Insufficient Growth Even After Shares Climb 32%
Mar 08Financial Position Analysis
Short Term Liabilities: 300644's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 300644's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥263.0M).
Debt to Equity History and Analysis
Debt Level: 300644's net debt to equity ratio (31.2%) is considered satisfactory.
Reducing Debt: 300644's debt to equity ratio has increased from 16.4% to 54.1% over the past 5 years.
Debt Coverage: 300644's debt is well covered by operating cash flow (33.9%).
Interest Coverage: 300644's interest payments on its debt are well covered by EBIT (4.1x coverage).